Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Seattle, Washington 98103


The purpose of this study is to evaluate if lifespan integration (LI) therapy reduces posttraumatic stress symptoms following a motor vehicle accident (MVA) trauma

Study summary:

Studies estimate a substantial proportion of MVA survivors, ranging from 9.4% to 59.9%, will develop PTSD following an accident (Blanchard & Hickling, 2004). Based on conservative estimates, past research, indicates that MVA-related PTSD may affect 2.5 to 7 million persons in the United States (Blanchard & Hickling). Furthermore, two seminal epidemiological studies (Kessler et al., 1995; Norris, 1992) that focused on causes of adult PTSD identified MVAs as the most frequent trauma resulting in PTSD. For these reasons, MVA-resultant PTSD represents a significant public health problem that needs not only to be thoroughly understood, but addressed with successful mental health treatment options (Beck & Coffey, 2007; Blanchard & Hickling, 1997, 2004; Bryant et al., 1998; Taylor et al., 1999; Taylor et al., 2001). Although there is empirical literature on the treatment of PTSD following an MVA, additional efficacious and rigorously conducted studies with statistical underpinnings are required to determine the results that can be expected from alternative models of care (Beck & Coffey; Blanchard & Hickling, 1997, 2004).


Inclusion Criteria: - Involved in or witnessed a car accident at least 6 months ago. - PTSD or distress or impairment in important areas of functioning following the car accident Exclusion Criteria: - moderate or severe head injury - current mental health treatment for the MVA-related problem - severe chronic pre-injury mental health problems

Study is Available At:

Original ID:




Secondary ID:

Study Acronym:

Brief Title:

Lifespan Integration for Posttraumatic Stress Disorder From an Auto Accident

Official Title:

Lifespan Integration Therapy for Posttraumatic Stress Disorder of Adults Involved in an Auto Accident

Overall Status:


Study Phase:




Minimum Age:

18 Years

Maximum Age:


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

Argosy University

Oversight Authority:

United States: Institutional Review Board

Reasons Why Stopped:

Study Type:


Study Design:

Allocation: Randomized, Endpoint Classification: S

Number of Arms:


Number of Groups:


Total Enrollment:


Enrollment Type:


Overall Contact Information

Official Name:Frances Parks, PhD
Study Chair
Argosy University Seattle

Study Dates

Start Date:October 2010
Completion Date:January 2012
Completion Type:Actual
Primary Completion Date:July 2011
Primary Completion Type:Actual
Verification Date:January 2015
Last Changed Date:January 13, 2015
First Received Date:December 15, 2010

Study Outcomes

Outcome Type:Primary Outcome
Measure:Clinicians Administered PTSD Scale
Time Frame:following the final treatment session (average of 6 weeks from treatment start date)
Safety Issues:False
Description:Participants will be assessed with the CAPS following the final treatment session (up to 5 treatment sessions).
Outcome Type:Secondary Outcome
Measure:Personality Assessment Inventory
Time Frame:following the final treatment session (average of 6 weeks from treatment start date)
Safety Issues:False

Study Interventions

Intervention Type:Behavioral
Name:Lifespan Integration Therapy
Description:LI treatment guides the client to imaginally visit past memories, and then leads her or him forward through time to the present using a concept referred to as the time line. Beginning with the individual's memories from the traumatic experience, the time line first follows memories from the days and weeks after the trauma, then season by season to the present, and is reviewed in ongoing sessions as increasing details of the traumatic event are uncovered.
Arm Name:Lifespan Integration Therapy (LI)
Intervention Type:Behavioral
Name:Lifespan Integration- Control
Description:Participants selected for the control group will be treated 4 weeks following initial contact. Treatment is the same as for the Experimental Group.
Arm Name:Waitlist Control- Lifespan Integration

Study Arms

Study Arm Type:Active Comparator
Arm Name:Waitlist Control- Lifespan Integration
Study Arm Type:Experimental
Arm Name:Lifespan Integration Therapy (LI)

Study Agencies

Agency Class:Other
Agency Type:Lead Sponsor
Agency Name:Argosy University

Sample and Retention Information

There are no available Sample and Retention Information

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

This study is not currently recruiting Study Participants. The form below is not enabled.